抗血管内皮生长因子药物治疗牵牛花综合征合并黄斑新生血管1例_Chinese Journal of Ocular Fundus Diseases

Authors：

陈智萍 ,  游志鹏 , 毛子清 , 吴泠瑶 , 谈赟玉 , 苏晓涵 , 田西凤

南昌大学附属眼科医院, 南昌 330006;

Corresponding author：

游志鹏, Email: yzp@sina.com

Keywords：

牵牛花综合征; 先天性视盘发育异常; 黄斑新生血管; 病例报告

DOI：

10.3760/cma.j.cn511434-20221019-00553

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陈智萍, 游志鹏, 毛子清, 吴泠瑶, 谈赟玉, 苏晓涵, 田西凤. 抗血管内皮生长因子药物治疗牵牛花综合征合并黄斑新生血管1例. Chinese Journal of Ocular Fundus Diseases, 2024, 40(2): 148-149. doi: 10.3760/cma.j.cn511434-20221019-00553 Copy

1.	佘凯芩, 张琦, 赵培泉. 牵牛花综合征诊断治疗与遗传和发病机制的研究现状及进展[J]. 中华眼底病杂志, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.She KQ, Zhang Q, Zhao PQ. The status and progress of morning glory syndrome[J]. Chin J Ocul Fundus Dis, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.
2.	杨依柳, 杨婷婷, 陆方, 等. 新生血管性老年性黄斑变性亚型报告的国际新命名专家共识解读[J]. 中华眼底病杂志, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.Yang YL, Yang TT, Lu F, et al. Brief interpretation of the consensus nomenclature for reporting neovascular age-related macular degeneration data[J]. Chin J Ocul Fundus Dis, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.
3.	Dempster AG, Lee WR, Forrester JV, et al. The 'morning glory syndrome'-a mesodermal defect?[J]. Ophthalmologica, 1983, 187(4): 222-230. DOI: 10.1159/000309330.
4.	吴素兰, 毛剑波, 沈丽君. 玻璃体腔注射雷珠单抗治疗儿童牵牛花综合征合并脉络膜新生血管一例[J]. 中华眼底病杂志, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.Wu SL, Mao JB, Shen LJ. A case of intravitreal injection of leizumab in the treatment of morning glory syndrome complicated with choroidal neovascularization in children[J]. Chin J Ocul Fundus Dis, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.
5.	Zou YH, She KQ, Ren JN, et al. Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome[J]. Int J Ophthalmol, 2022, 15(5): 766-772. DOI: 10.18240/ijo.2022.05.12.

1. 佘凯芩, 张琦, 赵培泉. 牵牛花综合征诊断治疗与遗传和发病机制的研究现状及进展[J]. 中华眼底病杂志, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.She KQ, Zhang Q, Zhao PQ. The status and progress of morning glory syndrome[J]. Chin J Ocul Fundus Dis, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.
2. 杨依柳, 杨婷婷, 陆方, 等. 新生血管性老年性黄斑变性亚型报告的国际新命名专家共识解读[J]. 中华眼底病杂志, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.Yang YL, Yang TT, Lu F, et al. Brief interpretation of the consensus nomenclature for reporting neovascular age-related macular degeneration data[J]. Chin J Ocul Fundus Dis, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.
3. Dempster AG, Lee WR, Forrester JV, et al. The 'morning glory syndrome'-a mesodermal defect?[J]. Ophthalmologica, 1983, 187(4): 222-230. DOI: 10.1159/000309330.
4. 吴素兰, 毛剑波, 沈丽君. 玻璃体腔注射雷珠单抗治疗儿童牵牛花综合征合并脉络膜新生血管一例[J]. 中华眼底病杂志, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.Wu SL, Mao JB, Shen LJ. A case of intravitreal injection of leizumab in the treatment of morning glory syndrome complicated with choroidal neovascularization in children[J]. Chin J Ocul Fundus Dis, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.
5. Zou YH, She KQ, Ren JN, et al. Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome[J]. Int J Ophthalmol, 2022, 15(5): 766-772. DOI: 10.18240/ijo.2022.05.12.

Previous Article
Elevated blood pressure increases risk of proliferative diabetic retinopathy: a Mendelian randomization study
Next Article
急性渗出性多形性卵黄样黄斑病变1例

Chinese Journal of Ocular Fundus Diseases

抗血管内皮生长因子药物治疗牵牛花综合征合并黄斑新生血管1例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content